Publications
20
Citations
850
Est. group size
~2
Recurring co-author estimate
Active years
34
Publishing since 1992
This researcher works in blood cancer and blood disorder research, with a focus on clonal hematopoiesis (a condition where certain blood stem cells multiply more than others, sometimes signaling increased disease risk) and its links to inflammation, leukemia, and clotting disorders. Work also includes clinical trial follow-up for chronic lymphocytic leukemia (CLL) treatment and studies extending clonal hematopoiesis research to companion dogs as a comparative model.
Publication output has been modest and uneven over the last decade, rising to a small peak around 2021-2022 before a gap in 2023-2024 and a slight uptick in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Clonal hematopoiesis of indeterminate potential in the companion dog
Leukemia · 2022
- Four-year follow-up from a phase 2 study of obinutuzumab, ibrutinib, and venetoclax in CLL.
Journal of Clinical Oncology · 2022
- Abstract 1620: Clonal hematopoiesis of indeterminate potential in the companion dog
Cancer Research · 2022
- Rate of Clonal Hematopoiesis in Patients with Venous Thromboembolism
Blood · 2021
- Blood×6
- Leukemia×3
- Journal of Clinical Oncology×2
- Journal of Clinical Investigation×1
- Cell Reports×1
- John C. Byrd
Medicine · The Ohio State University
- Amy S. Ruppert
Medicine · The Ohio State University
- Cecelia Miller
Medicine · The Ohio State University
- Daniel Jones
Medicine · The Ohio State University
- Michael R. Grever
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile